Adolescent Asthma Study

Ages Eligible for Study: Ages 12-21
Sexes Eligible for Study: All


The VECTOR Study is a clinical research study for those with moderate to severe asthma, looking at flu vaccination alongside treatment with an investigational asthma drug. Approximately 100 participants are expected to take part in the USA.

To qualify for the VECTOR Study, you must:

  • be aged 12-21 years
  • have experienced moderate to severe asthma for at least one year
  • be eligible for the seasonal flu vaccine.

There are other criteria that you will need to meet to qualify, which the study team will discuss with you.

For further information about the VECTOR Study, contact our study team  by emailing or calling 210-851-8560

Apply Now:


Leave a Reply

Your email address will not be published. Required fields are marked *